openPR Logo
Press release

Hemoglobinopathies Market size is expected to witness significant growth from 2016 to 2023

11-08-2016 05:01 PM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Global Market Insights, Inc.

Global Market Insights, Inc.

Hemoglobinopathies Market size was valued at over USD 4 billion in 2015. High occurrence in underdeveloped nations such as Arab nations, Sub-Saharan region and South East Asia is a major growth driver.

Other key reasons for disease prevalence include lack of patient awareness, unmet needs for treatment, and absence of permanent cure. Lack of awareness for treatment and diagnosis of such rare diseases generates huge untouched opportunities in the industry. The hemoglobinopathies market is anticipated to grow on a global scale owing to improving health care infrastructure.

Hemoglobinopathy is a group of inherited disorders caused due to abnormal production or aberration in hemoglobin structure. Different disorders comprise sickle cell anemia, S-C and hemoglobin C disorder and various forms of thalassemia. Originally found in the Mediterranean area and large parts of Asia and Africa, they now have presence across the globe on account of growing migration.

Request for an in-depth table of contents for this report @

Most common tools/tests for diagnosis of hemoglobinopathies and thalassemia disorders are pre-implantation genetic diagnosis, genetic and blood testing, alkaline and acid gel electrophoresis, hemoglobin electrophoresis, prenatal genetic testing and HbA2 quantification by ion exchange column chromatography. Increased awareness about genetic testing for diagnosis of sickle cell anemia and other disorders is expected to contribute toward revenue growth in the near future. Genetic testing is an emerging cost-effective approach to reduce the pervasiveness of the disease.

Common therapies available are blood transfusion, bone marrow transplant, chelation therapy and hydroxyurea. Higher capital & reagent costs and inadequate required skills and experience for interpreting the results due to data complexity are among major restraints.

Globally, incidence of thalassemia is about 0.2 million patients, whereas sickle cell anemia has higher occurrence of around 20 million. Due to unawareness about disease, death to survival ratio for the patients has increased. However, increased government and private organizations initiatives for spreading awareness about hemoglobin diseases are expected to drive hemoglobinopathies market growth over the forecast period. Advanced diagnostics and therapeutics will likely fuel industry growth in the coming years. In 2010, the Centers for Disease Control (CDC) in collaboration with National Heart, Lung and Blood Institute established the Registry and Surveillance System for Hemoglobinopathies (RuSH) project for collecting initial state-specific information about people with sickle cell disease and thalassemia.

Make an inquiry for purchasing this report @

The industry is divided into sickle cell diseases, thalassemia (alpha and beta), and other disorders such as hereditary elliptocytosis. Mutations in gene encoding for globins generate different hereditary disorders, leading to blood diseases such as sickle cell disease and thalassemia. Sickle cell anemia disease and thalassemia diagnostics and therapeutic market are expected to exhibit growth over the forecast timeframe due to increase in patient awareness about the disorders and consequent progress in diagnosis and treatment.

In 2015, North America was the largest revenue generating region with around USD 1.2 billion owing to rise in R&D investments, better compensation state, and presence of high quality healthcare infrastructure. Asia Pacific hemoglobinopathies market share is anticipated to increase at 9% CAGR due to rising patient awareness and introduction of manufactured and low cost diagnostic kits. Sickle cell anemia is the most prevalentdisease in West Africa, with nearly 20% of people having sickle cell trait and about 2% of total babies born with a form of the disease. In many regions of Europe, hemoglobin (Hb) disorders are classified as prevalent diseases.

In the U.S., nearly 1,000 babies are born with sickle cell diseases every year. Increasing pervasiveness of several hemoglobinopathy disorders and high level of awareness about related genetic testing has boosted regional growth. The disease does not have a permanent treatment resulting in growing demand for novel products in the pharmaceutical industry.

Key industry players comprise Alnylam Pharmaceuticals, Gamida Cell, Biogen Idec, AcceleronPharma, Sangamo BioSciences, Anthera Pharmaceuticals, Global Blood Therapeutics, Genetix Pharmaceuticals, Mast Therapeutics, Prolong Pharmaceuticals, Emmaus Medical, Calgene Corporation, Invenux, Optinova Ab, and HemaQuest Pharmaceuticals. Companies are aiming on the partnership and licensing deals for sharing the research and development platform. In 2014, Sangamo BioSciences and Biogen Idec declared collaboration agreement that targeted hemoglobinopathies market therapeutics development.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1 888-689-0688

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemoglobinopathies Market size is expected to witness significant growth from 2016 to 2023 here

News-ID: 379864 • Views: 281

More Releases from Global Market Insights, Inc.

Robotic Prosthesis Market Dynamics, Forecast, Analysis and Supply Demand 2019-20 …
Robotic prosthesis market size is expected to grow significantly from 2019 to 2025. Robotic prosthesis market is primarily driven by growing demand for prosthetic implants owing to due to rise in number of accidents, severe injuries, tumors as well as congenital anomalies. Growing investments in R&D to integrate intelligent mechatronics, advanced sensing and control for attaining higher order lost sensorimotor functions, have enabled introduction of advanced technology within the devices
Anal Fistula Surgical Treatment Market Growth, Opportunities, Industry Applicati …
Anal fistula surgical treatment size is expected to grow significantly from 2019 to 2025. The anal fistula surgical treatment market is projected to witness lucrative growth over the coming years due to the increasing prevalence of inflammatory bowel diseases. Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal (GI) tract that includes both ulcerative colitis and crohn disease. Some of the symptoms of inflammatory bowel diseases are
Healthcare Fabrics Market Outlook 2019 - Growth Drivers, Opportunities and Forec …
Healthcare fabrics market size is expected to grow significantly from 2019 to 2025. The healthcare fabrics market is estimated to witness lucrative growth over the coming years owing to increasing consumer awareness regarding the usage of hygiene products along with the improved quality of healthcare fabrics. The fabrics play a vital role in the healthcare textile industry as they are used in various medical applications. With the changing lifestyle, personal
Veterinary Equipment and Disposables Market Growth, Opportunities, Industry Appl …
Veterinary Equipment and Disposables Market size is projected to experience significant growth from 2019 to 2025. The veterinary equipment and disposables market is estimated to witness considerable growth over the forth coming years. These equipments and disposables are intended for diagnosis, monitoring and treatment of various health conditions associated with animals. High growth is attributable to increasing prevalence of zoonotic diseases coupled with rising trend of pet adoption in both

All 5 Releases

More Releases for Pharmaceuticals

Global Halal Pharmaceuticals Market 2019 - CCM Pharmaceuticals, Pharmaniaga, Ros …
This new report by Eon Market Research, titled “Global Halal Pharmaceuticals Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Halal Pharmaceuticals industry at a global as well as regional and country level. Key facts analyzed in this report include the Halal Pharmaceuticals market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study
Topical Antibiotic Pharmaceuticals Market 2016-2026 | Teva Pharmaceuticals, Perr …
Topical antibiotics are applied to a certain area of the skin to kill infections. Application of topical antibiotics has a number of advantages upon comparison of systemic delivery in the treatment of skin infections. Skin and soft tissue infections (SSTIs) involve microbial invasion of the skin and underlying soft tissues infections are one of the most commonly occurring conditions amongst people. Most of these infections are minor and chronic in
Synthetic Opioids Market to 2016-2024: Pharma, Pfizer Inc., Janssen Pharmaceutic …
Researchmoz added Most up-to-date research on "North America Market Study on Synthetic Opioids: Large Number of Prescriptions of Oxycodone and Hydrocodone Amplifying the Semi-Synthetic Opioids Market" to its huge collection of research reports. Manufacturers of opioids have witnessed tremendous growth in consumption in the last decade. This stupendous growth can be attributed to the absence of regulatory policies and lack of product knowledge among physicians. However, the scenario has changed and
Halal Pharmaceuticals Market Report 2018 Companies included CCM Pharmaceuticals, …
We have recently published this report and it is available for immediate purchase. For inquiry Email us on: ********* This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
Halal Pharmaceuticals 2018 Global Market Key Players -CCM Pharmaceuticals, Pharm …
Halal Pharmaceuticals Market 2018 Wiseguyreports.Com Adds “Halal Pharmaceuticals – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Description:  In this report, the global Halal Pharmaceuticals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions,
Opioids Drugs Market 2016 - Johnson & Johnson, Teva pharmaceuticals, Purdue Phar …
Market Research Report on Opioids Drugs Market 2016 is a professional and in-depth study on the current state of the Opioids Drugs worldwide. First of all, " Global Opioids Drugs Market 2016 " report provides a basic overview of the Opioids Drugs industry including definitions, classifications, applications and Opioids Drugs industry chain structure. Major Companies Covered in this report:- Johnson & Johnson Teva pharmaceuticals Purdue Pharma King Pharmaceuticals Orexo Pharmaceuticals Endo Pharmaceuticals Get Sample Copy Of Report @